These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 421493)

  • 41. Cost-effectiveness of a hydroquinone/tretinoin/fluocinolone acetonide cream combination in treating melasma in the United States.
    Alikhan A; Daly M; Wu J; Balkrishnan R; Feldman SR
    J Dermatolog Treat; 2010 Sep; 21(5):276-81. PubMed ID: 20055711
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Usefulness of a narrow-band reflectance spectrophotometer in evaluating effects of depigmenting treatment.
    Yoshimura K; Harii K; Masuda Y; Takahashi M; Aoyama T; Iga T
    Aesthetic Plast Surg; 2001; 25(2):129-33. PubMed ID: 11349303
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Objective assessment of erythema and pigmentation of melasma lesions and surrounding areas in long-term management regimens with triple combination.
    Hexsel D; Soirefmann M; Fernandes JD; Siega C
    J Drugs Dermatol; 2014 Apr; 13(4):444-8. PubMed ID: 24719064
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The use of 4% hydroquinone, 0.1% tretinoin, and 0.1% betamethasone creams to prevent hyperpigmentation of split-thickness skin grafts in Long-Evans rats.
    Ozbey R; Okur MI
    J Cosmet Dermatol; 2020 Oct; 19(10):2663-2668. PubMed ID: 32030870
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Instrumental analysis of the pattern of improvement and that of recurrence of melasma in Thai females treated with Kligman-Willis triple combination therapy: confirmation by using its two different formulae.
    Pratchyapruit W; Vashrangsi N; Sindhavananda J; Tagami H
    Skin Res Technol; 2011 May; 17(2):226-33. PubMed ID: 21261747
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A new bleaching protocol for hyperpigmented skin lesions with a high concentration of all-trans retinoic acid aqueous gel.
    Yoshimura K; Harii K; Aoyama T; Shibuya F; Iga T
    Aesthetic Plast Surg; 1999; 23(4):285-91. PubMed ID: 10441721
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nail staining from hydroquinone cream.
    Ozluer SM; Muir J
    Australas J Dermatol; 2000 Nov; 41(4):255-6. PubMed ID: 11105373
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Topical use of hydroquinone as a depigmenting agent.
    Arndt KA; Fitzpatrick TB
    JAMA; 1965 Nov; 194(9):965-7. PubMed ID: 5897965
    [No Abstract]   [Full Text] [Related]  

  • 49. Melasma treatment with pulsed-dye laser and triple combination cream: a prospective, randomized, single-blind, split-face study.
    Passeron T; Fontas E; Kang HY; Bahadoran P; Lacour JP; Ortonne JP
    Arch Dermatol; 2011 Sep; 147(9):1106-8. PubMed ID: 21931054
    [No Abstract]   [Full Text] [Related]  

  • 50. [Depigmentation for cosmetic purposes: prevalence and side-effects in a female population in Senegal].
    Raynaud E; Cellier C; Perret JL
    Ann Dermatol Venereol; 2001; 128(6-7):720-4. PubMed ID: 11460033
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Methods and means for pigmentation and depigmentation. Sense or nonsense?].
    Hegyi V; Hegyi J
    Hautarzt; 2010 Jul; 61(7):586-92. PubMed ID: 20549480
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical trial of bleaching treatment with 10% all-trans retinol gel.
    Yoshimura K; Momosawa A; Aiba E; Sato K; Matsumoto D; Mitoma Y; Harii K; Aoyama T; Iga T
    Dermatol Surg; 2003 Feb; 29(2):155-60; discussion 160. PubMed ID: 12562345
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cosmetic and dermatology: bleaching creams.
    Engasser PG; Maibach HI
    J Am Acad Dermatol; 1981 Aug; 5(2):143-7. PubMed ID: 7021611
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management of dyschromias in ethnic skin.
    Halder RM; Richards GM
    Dermatol Ther; 2004; 17(2):151-7. PubMed ID: 15113282
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Letter: Topical vitamin A acid.
    Jarrett A; Spearman RI
    J Dermatol; 1975 Mar; 2(1):51-2. PubMed ID: 1104684
    [No Abstract]   [Full Text] [Related]  

  • 56. Randomized control trial outcomes of tranexamic acid combination serum as a depigmenting agent for the use in healthy individuals.
    Anwar AI; Wahab S; Widita W; Nurdin AR; Budhiani S; Seweng A
    Dermatol Ther; 2019 Nov; 32(6):e13146. PubMed ID: 31664751
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Topical use of hydroquinone for depigmentation.
    Spencer MC
    JAMA; 1965 Nov; 194(9):962-4. PubMed ID: 5897964
    [No Abstract]   [Full Text] [Related]  

  • 58. Monobenzylether of hydroquinone.
    Bentley-Phillips B
    Br J Dermatol; 1978 Dec; 99(6):719. PubMed ID: 737135
    [No Abstract]   [Full Text] [Related]  

  • 59. Hydroquinone--a harmful agent.
    Fernandes D
    S Afr Med J; 2000 Sep; 90(9):829. PubMed ID: 11081118
    [No Abstract]   [Full Text] [Related]  

  • 60. Acquired hypomelanosis in a Guyanese.
    Kelly MA
    Br J Dermatol; 1973 Jul; 89(1):92-3. PubMed ID: 4788321
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.